TrialJournal of the American Heart Association2021

Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel-Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events.

Kallirroi Kalantzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.